Bio Rad Net Worth

Bio Rad Net Worth Analysis

Bio Rad Target Price Consensus

Bio Rad Target Price Projection

Bio Rad's current and average target prices are 256.68 and 404.33, respectively. The current price of Bio Rad is the price at which Bio Rad Laboratories is currently trading. On the other hand, Bio Rad's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Bio Rad Laboratories and the information provided on this page.

Know Bio Rad's Top Institutional Investors

Note, although Bio Rad's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Bio Rad's market capitalization trends

The company currently falls under 'Mid-Cap' category with a total capitalization of 7.19 B.

Project Bio Rad's profitablity

The company has Net Profit Margin of (0.72) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 0.09 %, which entails that for every 100 dollars of revenue, it generated $0.09 of operating income.

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Evaluate Bio Rad's management efficiency

Bio Rad Laboratories has Return on Asset of 0.0155 % which means that on every $100 spent on assets, it made $0.0155 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.2409) %, meaning that it generated no profit with money invested by stockholders. Bio Rad's management efficiency ratios could be used to measure how well Bio Rad manages its routine affairs as well as how well it operates its assets and liabilities. As of the 22nd of March 2025, Return On Tangible Assets is likely to grow to -0.2. In addition to that, Return On Capital Employed is likely to drop to 0.03. At this time, Bio Rad's Total Assets are very stable compared to the past year. As of the 22nd of March 2025, Non Current Assets Total is likely to grow to about 5.9 B, while Non Currrent Assets Other are likely to drop (616 M).

Bio Rad Corporate Filings

Bio Rad time-series forecasting models is one of many Bio Rad's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bio Rad's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Bio Rad Earnings Estimation Breakdown

The calculation of Bio Rad's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Bio Rad is estimated to be 1.8104 with the future projection ranging from a low of 1.67 to a high of 2.02. Please be aware that this consensus of annual earnings estimates for Bio Rad Laboratories is based on EPS before non-recurring items and includes expenses related to employee stock options.

Bio Rad Earnings Projection Consensus

Bio Rad Earnings History

Earnings estimate consensus by Bio Rad Laboratories analysts from Wall Street is used by the market to judge Bio Rad's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Bio Rad's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods. At this time, Bio Rad's Retained Earnings are very stable compared to the past year. As of the 22nd of March 2025, Retained Earnings Total Equity is likely to grow to about 12 B, though Earnings Yield is likely to grow to (0.19). As of the 22nd of March 2025, Common Stock Shares Outstanding is likely to grow to about 29.1 M, though Net Loss is likely to grow to (4 B).

Hype Prediction Low Estimated High 252.13 254.47 256.81 Details

Intrinsic Valuation Low Real High 233.06 235.40 279.92 Details

Naive Forecast Low Next High 254.89 257.22 259.56 Details

6 Analysts Consensus Low Target High 367.94 404.33 448.81 Details

Note that many institutional investors and large investment bankers can move markets due to the volume of Bio assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Bio Rad. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Bio Rad's stock price in the short term.

Bio Rad Earnings per Share Projection vs Actual

Actual Earning per Share of Bio Rad refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Bio Rad Laboratories predict the company's earnings will be in the future. The higher the earnings per share of Bio Rad, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Bio Rad Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Bio Rad, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Bio Rad should always be considered in relation to other companies to make a more educated investment decision.

Bio Quarterly Analyst Estimates and Surprise Metrics

Bio Rad Corporate Directors

When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:

How To Invest In Bio Details

Is Bio Stock a good investment? Details

What is Bio Rad's Net Worth? Details

Largest Life Sciences Tools & Services Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details